Excel Industries Q4 FY26 Revenue up 13% to ₹281 Cr, FY26 Revenue up 12% to ₹1,094 Cr
Excel Industries reported Q4 FY26 revenue of ₹281 crore, up 13% YoY, and FY26 revenue of ₹1,094 crore, up 12% YoY. The growth was driven by agrochemical intermediates and performance solutions. Exports grew 26% YoY. The company operationalized a new R&D center and faces challenges in raw material pricing.
The revenue growth is significant, but the impact is moderated by concerns over rising raw material costs and potential demand fluctuations due to 'El Niño' forecasts, which introduce some uncertainty into the outlook.
The company reported positive year-on-year growth in revenue for both the quarter and the full fiscal year, driven by strong demand and price realization. The operationalization of a new R&D center also indicates a focus on future growth and innovation.
Excel Industries Limited has announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a revenue of ₹281 crore for Q4 FY26, marking a 13% year-on-year increase, primarily driven by higher demand for agrochemical intermediates and improved price realization for key products. The adjusted EBITDA margins for the quarter stood at 8%.
For the full fiscal year FY26, the company's revenue grew by 12% year-on-year to ₹1,094 crore. This growth was attributed to strong demand for key products and better price realization, further boosted by capacity expansion in Biocides within the performance solutions segment. Exports contributed 16% and 20% of total revenue in Q4 and FY26, respectively, with exports revenue growing by 26% year-on-year.
Adjusted EBITDA margins for FY26 were 10%, compared to 12.3% in FY25, impacted by increased input material costs. The company maintained its market share in key products and continues to focus on product portfolio diversification. A new Corporate R&D Center was operationalized in Rabale, Navi Mumbai, underscoring the company's commitment to innovation.
The outlook indicates continued focus on biocides with plans for new product launches. Contract manufacturing projects are on track. While operations in April-May were smooth, the company notes concerns regarding potential raw material price increases due to "El Niño" forecasts, impacting demand for agrochemical intermediates. Availability and pricing of key raw materials remain a challenge, and the company plans to remain agile and proactive in its response.
What to do with a filing like this
Excel Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Excel Industries Limited. Read the original for the full detail.